Investigations on micellization and surface properties of sodium dodecyl sulfate in aqueous solutions of triflupromazine (cas 146-54-3) hydrochloride at different temperatures

Add time:09/30/2019    Source:infona.pl

Micellization behavior of sodium dodecylsulfate (SDS) has been studied in the presence of phenothiazine drug triflupromazine (cas 146-54-3) hydrochloride (TFP) in the concentration range (0.01–0.50mM) in water as well as in aqueous solutions of ethanol (1–10%, v/v) using conductivity and surface tension measurements. Critical micelle concentration (CMC), degree of micelle dissociation (β), Gibbs free energy of micellization (ΔGomic), standard enthalpy (ΔHomic) and entropy (ΔSomic), maximum surface excess concentration (Γmax), minimum area per surfactant molecule (Amin), Gibbs free energy of adsorption (ΔGoads) and packing parameter (p) have been calculated from the above measurements. CMC values decrease with concentration of ethanol as well as of TFP in water. However in aqueous ethanol solutions, CMC values of SDS do not follow a regular decrease with TFP concentration. Surface parameters, Γmax and Amin indicate comparatively less availability of surfactant molecules at the air–water interface in the presence of additives. The p values suggest that the micellar shape remains the same in the studied concentration range of TFP as well as ethanol. 1H NMR spectroscopy has also been employed to acquire an idea about the nature of molecular interactions prevailing among the reacting species from the changes in chemical shift observed.

We also recommend Trading Suppliers and Manufacturers of triflupromazine (cas 146-54-3). Pls Click Website Link as below: cas 146-54-3 suppliers

Prev:Determination of the partition coefficient of triflupromazine (cas 146-54-3) between phosphatidylcholine vesicles and water by 1 9 F nuclear magnetic resonance spin-lattice relaxation time measurement
Next:Second-Derivative Synchronous Fluorescence Spectroscopy for the Simultaneous Determination of FLUPHENAZINE HYDROCHLORIDE (cas 146-56-5) and Nortriptyline Hydrochloride in Pharmaceutical Preparations)